iShares US Pharmaceuticals ETF
IHE
IHE
149 hedge funds and large institutions have $345M invested in iShares US Pharmaceuticals ETF in 2025 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 34 increasing their positions, 43 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
21% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 43
Holders
149
Holding in Top 10
–
Calls
$212K
Puts
–
Top Buyers
| 1 | +$3.07M | |
| 2 | +$2.73M | |
| 3 | +$1.9M | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.02M |
| 5 |
GS
GTS Securities
New York
|
+$509K |
Top Sellers
| 1 | -$12.4M | |
| 2 | -$11.9M | |
| 3 | -$5.91M | |
| 4 |
Two Sigma Investments
New York
|
-$4.43M |
| 5 |
PCA
Pallas Capital Advisors
Braintree,
Massachusetts
|
-$3.83M |
